Consideration of breast cancer subtype in targeting the androgen receptor.
Venema CM, Bense RD, Steenbruggen TG, Nienhuis HH, Qiu SQ, van Kruchten M, Brown M, Tamimi RM, Hospers GAP, Schröder CP, Fehrmann RSN, de Vries EGE.
Venema CM, et al. Among authors: bense rd.
Pharmacol Ther. 2019 Aug;200:135-147. doi: 10.1016/j.pharmthera.2019.05.005. Epub 2019 May 8.
Pharmacol Ther. 2019.
PMID: 31077689
Free article.
Review.